Resapp Health (RAP)
ResApp Health Ltd. engages in the research and commercial development of drugs. It develops smart phone medical applications for the diagnosis and management of respiratory disease. The technology is based on a machine learning algorithm that uses sound alone without the need for additional hardware to diagnose and measure the severity of a respiratory condition. The company was founded on September 13, 2000 by John Majewski and is headquartered in Perth, Australia.
|Market Price at 11-12-2017||$0.07|
|Price to Earnings Ratio||-19.61|
|Market Capitalisation||$48.77 (million)|
|Return on Equity (ROE)||-88.37%|